WEKO3
アイテム
Clinical utility and limitations of FDG PET in detecting recurrent hepatocellular carcinoma in postoperative patients.
https://repo.qst.go.jp/records/46927
https://repo.qst.go.jp/records/46927af59883d-f1cd-474a-8c64-4cf92ae7a139
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2014-11-13 | |||||
タイトル | ||||||
タイトル | Clinical utility and limitations of FDG PET in detecting recurrent hepatocellular carcinoma in postoperative patients. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Hayakawa, Nobuyuki
× Hayakawa, Nobuyuki× Nakamoto, Yuji× Nakatani, Koya× Hatano, Etsuro× Seo, Satoru× Higashi, Tatsuya× Saga, Tsuneo× Uemoto, Shinji× Togashi, Kaori× 佐賀 恒夫 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The clinical usefulness of positron emission tomography (PET) with (18)F-fluorodeoxyglucose (FDG) for the detection of recurrent hepatocellular carcinoma (HCC) is controversial because HCC displays varying FDG avidity. The purposes of this study were to re-evaluate the utility of FDG PET for the detection of recurrent HCC, and to assess its prognostic value in a large series of postoperative patients. | |||||
書誌情報 |
International journal of clinical oncology 発行日 2013-12 |
|||||
出版者 | ||||||
出版者 | Springer-Verlag Tokyo | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1341-9625 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 24366329 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1007/s10147-013-0653-3 |